Effect of Intradialytic Exercises in Chronic Kidney Disease Patients
NCT ID: NCT06293092
Last Updated: 2024-03-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
60 participants
INTERVENTIONAL
2022-04-30
2024-01-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Intradialytic Resistance Versus Aerobic Exercise on Cardiovascular System in Patients on Regular Hemodialysis
NCT07054827
Interdialytic Resistance Exercises in with Chronic Kidney Diseases
NCT06862336
Acute Effects of Intradialytic Exercise on Cardiovascular Function in Hemodialysis Patients
NCT02753868
Effect of Intradialytic Blood Flow Restriction Training on Functional Capacity, Estimated Glomerular Filtration Rate and Health Related Quality of Life in Patients on Hemodialysis
NCT06976281
Resistance Exercise in Hemodialysis Patients
NCT06604221
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
1. Study Group A (20 patients) will receive intradialytic aerobic exercise and medical treatment.
2. Study Group B (20 patients) will receive intradialytic resistive exercise and medical treatment.
3. Control Group C (20 patients) will receive medical treatment only (HD session and drugs) Each patient will receive the treatment program three times per week for three months.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
control group C
receive hemodialysis sessions
hemodialysis sessions
hemodialysis sessions ,each patient will receive the treatment program three times per week for three months.
study group A aerobic exercise
receive hemodialysis sessions and intradialytic aerobic exercise
leg pedaling cycling device
Intradialytic aerobic cycling exercise program ,each patient will receive the treatment program three times per week for three months.
hemodialysis sessions
hemodialysis sessions ,each patient will receive the treatment program three times per week for three months.
study group B resistive exercise
receive hemodialysis sessions and intradialytic resistive exercise
sand bags
Intradialytic resistive exercise program , each patient will receive the treatment program three times per week for three months.
hemodialysis sessions
hemodialysis sessions ,each patient will receive the treatment program three times per week for three months.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
leg pedaling cycling device
Intradialytic aerobic cycling exercise program ,each patient will receive the treatment program three times per week for three months.
sand bags
Intradialytic resistive exercise program , each patient will receive the treatment program three times per week for three months.
hemodialysis sessions
hemodialysis sessions ,each patient will receive the treatment program three times per week for three months.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* They had a history of type II Diabetes more than five years.
* Their age will be ranged from 50-60 years old.
* They are Fit for exercise by functional assessment using six minute walk test.
* Their Hemoglobin level more than 10 g\\dl.
* Their Body Mass Index (BMI) will be ranged from "18.5" to "24.9".
Exclusion Criteria
* Severe orthopedic problems (for example fractures).
* Hepatic encephalopathy.
* Preexisting neuromuscular diseases (e.g. myasthenia gravis). •Severe chest diseases.
* Spinal cord injuries involved the phrenic nerve.
* Uncontrolled diabetes or hypertension
* Patients receiving inefficient hemodialysis session.
* Patients with other cause for inflammation e.g. malignancy and autoimmune disease.
* Active bleeding as alveolar hemorrhage, hemoptysis.
* Physical limitation that would limit cycling.
50 Years
60 Years
MALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Cairo University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Hazem Mohamed Yasin Abbas
physiotherapist
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Fayoum hospital
Al Fayyum, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
P.T.REC/012/004008
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.